Contributing to a sustainable future by proactively managing the environmental impact of medicines.
Develop tools to identify and predict potential environmental impacts associated with the use of human medicines.
Explore the feasibility of greener drug design and development with associated guiding principles.
Develop a framework to prioritise the environmental assessment of existing medicines based on risk.
Generate environmental data for up to 25 existing medicines based on their potential environmental risk to validate the prioritisation framework.
Launch an evidence-based transparent, public and easily accessible database collating physico-chemical and environmental properties (ecotoxicity, e-fate) as well as relevant metadata for human medicines.
Create a novel information and assessment guiding system to support regulators, water managers and other stakeholders in identifying and managing any potential environmental risks associated with the patient use of medicines.
Provide stakeholder guidance on how to use the PREMIER data, tools and assessment system in practice.
“PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 875508. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA”.